The Medicaid RAC Improvement Act of 2026 strengthens oversight of the Medicaid Recovery Audit Contractor program to improve how states identify and recover improper payments. It requires the Centers for Medicare and Medicaid Services to establish clear expiration dates for state exceptions to the program, mandate detailed annual reports on audit results, and ensure managed care organizations are included in these reviews. Additionally, the bill directs the agency to study barriers preventing states from participating and to launch a five-year demonstration project aimed at increasing state engagement. The legislation also extends the standard audit period to allow reviews of payments made over the previous four fiscal years.
The Keep Food Containers Safe from PFAS Act of 2026 prohibits the sale of food packaging that contains intentionally added PFAS chemicals starting on January 1, 2027. This law directly impacts manufacturers and distributors by banning the introduction of such packaging into interstate commerce. The bill specifically defines PFAS as a group of fluorinated organic chemicals that include at least one fully fluorinated methyl or methylene carbon atom. By amending the Federal Food, Drug, and Cosmetic Act, the legislation ensures that food containers sold across state lines will not include these specific substances.
The Modernizing Opioid Treatment Access Act 2.0 of 2026 allows licensed addiction medicine specialists to prescribe methadone for opioid use disorder to be dispensed directly through pharmacies, rather than requiring patients to visit traditional treatment clinics. Under this bill, these practitioners must use electronic prescribing and can only dispense liquid or dispersible tablet formulations, while pharmacies do not need separate registration to handle these prescriptions. The law also permits telemedicine for maintenance or detoxification treatment and requires doctors to obtain informed consent from patients regarding how privacy protections differ between clinic and pharmacy settings. Additionally, the Attorney General can revoke a doctor's registration if a state requests it, and the Drug Enforcement Administration must report annually on the number of registered providers and pharmacies involved in the program.
This bill, known as the Dismemberment Abortion Ban Act of 2026, prohibits physicians from performing abortions that involve dismembering an unborn child piece by piece or crushing it with instruments, with the specific intent of causing the child's death. The law defines an "unborn child" as a human organism from fertilization until birth and allows for exceptions only when the procedure is necessary to save the life of the mother due to a physical disorder, illness, or injury. While it bans this specific method, the bill explicitly states that other abortion methods remain legal for reasons such as rape or incest, and it removes the previous federal ban on partial-birth abortions from the legal code. Violators face criminal penalties including fines and up to two years in prison, while women undergoing these procedures are immune from prosecution. Additionally, the bill creates a civil remedy allowing women or parents of minors to sue physicians for money damages, psychological injury, and punitive damages if the ban is violated.
The Reproductive Health Care Training Act of 2026 directs the Health Resources and Services Administration to create a grant program that funds medical schools and health centers to expand abortion care training for students and clinicians. These funds are specifically designated for states where such comprehensive training is legally permitted, with a priority given to institutions serving minority populations or those training providers for medically underserved communities. The bill outlines how the money can be used to develop clinical curricula, support telehealth practices, offer scholarships, and build partnerships to improve access to abortion services. Additionally, the legislation requires recipients to submit annual reports on program performance while ensuring federal funds supplement rather than replace existing state or private funding.
The No Medicare Clawbacks Act of 2026 prevents group health plans from taking back money they have already paid for medical services if a patient later becomes eligible for Medicare benefits. This rule applies specifically when the medical care was provided during a period of retroactive Medicare coverage and the patient was current on their required health plan contributions at the time of service. By amending the Social Security Act, the bill ensures that individuals do not face financial penalties for receiving care before their Medicare eligibility is officially recognized. The legislation directly affects employers offering group health plans and their employees who might otherwise face recouped payments due to delayed Medicare enrollment.
The Medicare Cost Cap Act of 2026 establishes a $5,000 annual limit on out-of-pocket costs for Medicare fee-for-service beneficiaries starting in 2028, after which Medicare will cover 100% of additional covered expenses. This protection applies to all individuals enrolled in Medicare Part A or Part B and includes tracking mechanisms to notify patients and providers once the cap is reached. The bill also modifies eligibility rules for low-income assistance programs, aligning income thresholds between Medicare Savings Programs and Medicaid and expanding data sharing to streamline enrollment for qualifying beneficiaries.
The Residential Recovery for Seniors Act expands Medicare coverage to include three specific levels of residential treatment for substance use disorders: clinically managed low-intensity, clinically managed high-intensity, and medically managed services. To qualify for this coverage, facilities must meet strict standards regarding staffing, clinical assessments, and adherence to evidence-based criteria developed by recognized medical associations. The bill also establishes a new payment system that reimburses these facilities on a per-day basis, starting in fiscal year 2027, with rates initially set to cover 100% of their estimated costs.
The SAFER Health Act of 2026 strengthens privacy protections for individuals by prohibiting healthcare providers and related entities from disclosing information about abortions or pregnancy losses in legal proceedings without the individual's explicit consent. This rule applies to all types of legal cases, including civil, criminal, and administrative matters, with specific exceptions for defending against professional liability claims or investigating physical harm caused to the individual. The bill also requires health IT systems to separate this sensitive data from other records and mandates that the Department of Health and Human Services update existing regulations to enforce these privacy standards. Additionally, the law preempts any conflicting state laws that offer less privacy protection for this specific type of medical information.
The Specialized Infant Formula Protection Act aims to guarantee a steady supply of specialized formula for preterm babies by centralizing legal oversight. It grants federal courts the authority to hear lawsuits involving injuries from FDA-regulated preterm infant formula, regardless of whether the parties are from different states or involve foreign defendants. Additionally, the law allows defendants to move such cases from state courts to federal courts without needing permission from all other defendants. These changes are designed to prevent fragmented legal battles in various state courts that could disrupt the domestic supply of this critical medical product.